Neurological Immune-Related Adverse Events of IpilimumabPract Neurol 13:278-280, Bot, I.,et al, 2013
Neurotoxicity of Commonly Used Antineoplastic AgentsNEJM 291:75, 1271974., Weiss,H.,et al, 1974